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Abstract
Introduction: A combination of traditional cytology methods with fluorescence activated cell sorting (FACS) analysis of fine-needle 
aspiration biopsy (FNAB) material is considered a powerful diagnostic tool in the differential diagnosis of thyroid lesions suspected of 
mucosa-associated lymphoid tissue lymphoma (MALT-L).
The aim of this study was to demonstrate the FACS-based diagnostic process of thyroid lesions in a clinical situation where ultrasound 
and cytological examinations did not allow differentiation between Hashimoto’s thyroiditis (HT) and MALT-L.
Material and methods: The patients analysed in this study presented significantly different clinical courses of thyroid disease: quickly 
enlarging painless tumour of the thyroid right lobe in the first case, and chronic HT with palpable tumour in the thyroid isthmus in the 
second patient. Due to the suspicion of MALT-L resulting from indeterminate ultrasound and FNAB-cytology results, FNAB material 
was obtained from all the previously examined thyroid lesions and directly subjected to FACS assessment, encompassing κ/λ light chain 
restriction analysis, as well as measurements of B and T cell surface antigens. 
Results: The FACS analysis of FNAB material obtained from our patients did not show any definite signs of light chain restriction. Although 
one of the samples showed a borderline value of κ/λ ratio (κ/λ = 0.31), further immunophenotyping confirmed clonal expansion in none 
of the examined thyroid regions. Histopathological findings documented the diagnosis of HT in both clinical cases.
Conclusion: We believe that FACS represents a useful and reliable complementary diagnostic measure in FNAB-based differential diag-
nosis of lymphoproliferative thyroid disorders. (Endokrynol Pol 2015; 66 (1): 73–78)
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Streszczenie
Wstęp: Skojarzenie oceny cytologicznej oraz cytometrii przepływowej (FACS, fluorescence activated cell sorting) materiału uzyskanego 
podczas biopsji aspiracyjnej cienkoigłowej (BAC) jest uważane za niezwykle skuteczną metodę w diagnostyce różnicowej zmian tarczycy 
podejrzanych o obecność pozawęzłowego chłoniaka strefy brzeżnej systemu MALT (MALT-L).
Celem pracy było zaprezentowanie opartego na FACS procesu diagnostycznego zmian ogniskowych tarczycy u chorych, u których badanie 
ultrasonograficzne i cytologiczne nie umożliwiło zróżnicowania przewlekłego zapalenia tarczycy (HT, Hashimoto's thyroiditis) od MALT-L. 
Materiał i metody: Chorzy opisani w pracy charakteryzowali się całkowicie odmiennym przebiegiem klinicznym choroby tarczycy — 
ujawniającej się w pierwszym przypadku jako szybko powiększający się guz płata prawego, w drugim jako zmiana ogniskowa w cieśni 
u chorej z przewlekłym wywiadem HT. Ze względu na podejrzenie MALT-L postawione na podstawie badania cytologicznego oraz 
podejrzany wzorzec ultrasonograficzny, przeprowadzono ponownie BAC wszystkich wcześniej ocenianych zmian tarczycy, a uzyskany 
materiał poddano bezpośrednio ocenie za pomocą FACS, obejmującej analizę restrykcji łańcuchów lekkich immunoglobulin κ/λ oraz 
antygenów powierzchniowych limfocytów T i B.
Wyniki: Analiza FACS materiału uzyskanego za pomocą BAC nie ujawniła definitywnych cech restrykcji łańcuchów lekkich. Pomimo 
granicznych wartości współczynnika κ/λ (κ/λ = 0,31) w jednej z próbek, dalsza analiza fenotypowa nie potwierdziła klonalnej ekspansji 
w żadnym z badanych obszarów tarczycy. Wyniki histopatologiczne potwierdziły diagnozę przewlekłego zapalenia tarczycy w obu 
przypadkach klinicznych.
Wnioski: Cytometria przepływowa jest badaniem wiarygodnie uzupełniającym ocenę cytologiczną w diagnostyce różnicowej przewle-
kłego zapalenia tarczycy i limfoproliferacyjnych chorób tarczycy. (Endokrynol Pol 2015; 66 (1): 73–78)
Słowa kluczowe: biopsja aspiracyjna cienkoigłowa; cytometria przepływowa; przewlekłe zapalenie tarczycy; MALT
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Introduction
Flow cytometry or fluorescence activated cell sort-
ing (FACS) procedure does not belong to diagnostic 
standards in thyroid diseases. However, in some clinical 
cases it can significantly facilitate the final diagnosis. 
A combination of traditional cytology methods with 
FACS analysis of fine-needle aspiration biopsy (FNAB) 
material is considered to be a powerful diagnostic tool in 
haematological malignancies [1, 2, 3–6]. Assessment of 
κ/λ light chain clonality belongs to the most important 
procedures allowing differentiation between poly-
clonal reactive processes and monoclonal lymphoma 
[7, 8]. This applies, for example, to clinical cases where 
difficulties appear in differentiation between florid 
lymphocytic infiltration and non-Hodgkin’s lymphoma 
(NHL) of the thyroid [9]. Moreover it is a particularly im-
portant element in the diagnosis of mucosa-associated 
lymphoid tissue (MALT) lymphomas (MALT-L) [10]. 
Cytologically, this type of lymphoma is characterised 
by a very heterogeneous appearance of neoplastic in-
filtration [6]. In consequence, the traditional cytologic 
examination of FNAB material has been proven to be 
insufficient in the differential diagnosis of thyroid le-
sions suspected of MALT-L [11, 12]. In contrast to NHL, 
no clear literature data exists regarding the applicabil-
ity of FACS analysis of FNAB material in other rare 
lymphoproliferative processes of the thyroid, such as 
Hodgkin’s lymphoma.
Thyroid lymphoma is a rare disease, comprising ap-
proximately 2% of all thyroid malignancies [13]. Primary 
involvement of the thyroid is found in about 2.5% of all 
extranodal lymphomas [14]. Most thyroid lymphomas 
are B-cell lymphomas: more than 50% of cases are dif-
fuse large B-cell lymphoma (DLBCL), and 10–23 % of 
cases are extranodal marginal zone B-cell lymphomas, 
also known as MALT. Other subtypes of thyroid lym-
phomas include: follicular (10%), small lymphocytic 
(3%), and Hodgkin’s lymphoma (2%). Burkitt’s, T-cell, 
mantle cell and lymphoblastic lymphomas each account 
for less than 1% of cases [15–17].
The clinical picture of thyroid lymphoma is fre-
quently associated with a rapidly enlarging painless 
thyroid mass, leading to a compression of neck struc-
tures with cervical lymph-node enlargement. Many 
patients complain of unexplained exhaustion, dryness 
of mucosal surfaces, loss of weight, fever and night 
sweats — symptoms especially prominent in DLBCL 
patients [18].
Usually in such cases the diagnosis is not difficult. 
However, in some patients the thyroid tumours have an 
indolent course without clinical symptoms suggestive 
of an aggressive lymphoma. Such a pattern of disease 
usually occurs in MALT-L [19–21]. This NHL subtype 
develops outside lymph nodes (extranodal expansion). 
The cells of MALT-L typically express pan-B-cell mark-
ers, e.g. CD19 and CD20 and are negative for CD10 and 
CD5, although some cases of CD5 positive MALT-L 
have been reported [22]. Most MALT-L cases begin in 
the gastrointestinal tract, especially in the stomach. 
Other possible initial sites of MALT-L include the lungs, 
skin, salivary glands, ocular adnexa and the thyroid. In 
many cases, the development of MALT-L was linked to 
infectious factors (such as Helicobacter pylori in stomach, 
Chlamydia psittaci in ocular adnexa, Borrelia burgdorferi 
in skin) regarded as a primary source of chronic inflam-
matory reaction, leading in consequence to malignant 
transformation. Also autoimmune disorders associated 
with persistent immune processes in target organs (e.g. 
salivary gland in Sjögren syndrome) are considered 
as factors increasing the risk of developing MALT 
lymphoma. In the thyroid, a positive correlation of a 
long-term chronic autoimmune thyroiditis (such as 
Hashimoto’s thyroiditis, HT) and the risk of MALT-L 
have been suggested [23]. In the light of the aforemen-
tioned etiopathological findings, it is considered that 
the first line of treatment should be cessation of the 
irritating factor such as Helicobacter pylori or Chlamydia 
psittaci in gastrointestinal or conjunctival/orbital MALT 
lymphoma, respectively. In the case of the thyroid, such 
a scheme is, for obvious reasons, not feasible.
Thyroid tissue is normally devoid of lymphocytic 
populations. In HT, progressive loss of thyrocytes 
is typically associated with an increasing grade of 
lymphoid infiltrates and the formation of germinal 
centres. The atrophic form of HT is characteristic for 
most patients but in some cases, or in particular phases 
of thyroiditis, unilateral or bilateral thyroid gland en-
largement with the formation of nodules is observed. 
In such a clinical situation, the differentiation between 
inflammation and cancer represents often a serious 
diagnostic problem [24].
Material and methods
Here we present two patients with different clinical 
courses of thyroid disease. In both cases, diagnostic 
measures based on ultrasound of the neck and FNAB 
of the lesions were insufficient for full characterisation 
of the thyroid disorder. The diagnostic challenge was an 
inability to differentiate between MALT-L and HT [19].
Patient 1
A 50-year-old woman was admitted to the Depart-
ment of Endocrinology and Metabolic Diseases due 
to a quickly enlarging painless tumour of the thyroid 
right lobe. A physical examination revealed the pres-
ence of a firm right lobe tumour with a diameter of 
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4 cm. The left lobe was impalpable. Laboratory tests 
revealed normal serum concentrations of free thyroid 
hormone fractions (fT3 and fT4) and thyrotropin (TSH) 
and increased serum levels of anti-TPO and anti-Tg 
antibodies. Serum concentration of anti-TSH receptor 
antibody (TRAK) was normal. Due to the rapid, pain-
less volume increase of the right thyroid lobe paral-
leled by increased serum concentrations of anti-TPO 
and anti-Tg, diagnoses of anaplastic thyroid cancer or 
lymphoma were considered. Ultrasound examination 
demonstrated an asymmetry of the thyroid lobes: di-
ameters of right — 30 × 37 × 58 mm; left — 17 × 19 × 
× 41 mm. The entire right lobe had solid, heterogene-
ous, hypoechogenic structure with decreased blood 
flow (Power Doppler). The margin was blurred and 
poorly defined without a halo. In the left lobe a single 
focal lesion (10 × 13 × 15 mm) with a very similar ultra-
sound pattern was revealed. The ultrasound structure 
of the tissue surrounding left lobe lesion was normoe-
chogenic and homogeneous. In both lesions, the risk 
score of malignancy was assessed as intermediate on 
the basis of ultrasound characteristics (4 points in the 
right and 4.5 points in the left thyroid lobe) [25]. The 
patient underwent FNAB of both lobes — the domi-
nant lesion in the right lobe and the lesion in the left 
lobe. Cytological examination of the right lobe lesion 
revealed equivocal results, suggestive of MALT-L or 
HT. In the left lobe, cytology findings were consistent 
with HT characteristics.
Patient 2
A 46-year-old woman was seen in the endocrinol-
ogy department due to Hashimoto’s disease. The 
patient received LT4 supplementation (125 mcg per 
day). A physical examination revealed the pres-
ence of a tumour in the isthmus with a diameter of 
2 cm. Both lobes of the thyroid were characterised by 
a hard, uneven surface, without palpable nodules. 
Laboratory tests revealed normal serum concentra-
tions of free thyroid hormones (fT3 and fT4) and TSH 
and increased serum levels of anti-TPO and anti-Tg 
antibodies. Concentration of TRAK was normal. Ul-
trasound examination demonstrated hypoechogenic, 
heterogeneous structure of both thyroid lobes with 
decreased blood flow (Power Doppler): diameters — 
18 × 17 × 48 mm; left — 14 × 15 × 50 mm of the right 
and left thyroid lobe, respectively. In the border be-
tween right lobe and isthmus, ultrasound revealed a 
focal, solid, hypoechogenic lesion (19 × 15 × 17 mm) 
with hyperechogenic spots (probably microcalcifica-
tions). The blood flow was decreased (Power Dop-
pler) and the margin was blurred and poorly defined 
without a halo. The malignancy risk of the lesion was 
assessed as intermediate on the basis of ultrasound 
pattern — 4.5 points [25]. The patient underwent 
FNAB of both lobes and lesion in isthmus. Cytological 
examination revealed HT in both lobes, whereas the 
lesion in the isthmus proved to be cytologically inde-
terminate, with a suspicion of MALT-L or HT. 
Despite obvious differences in the clinical course, the 
results of FNAB examination in both cases were very 
similar and suggested the need for further differentia-
tion between MALT-L and HT.
Therapy in patients with MALT-L appearing as 
thyroid tumour encompasses radiotherapy in the case 
of localised disease and chemotherapy in disseminated 
cases [20]. These therapeutic procedures differ substan-
tially from the usual surgical treatment in patients with 
thyroid tumours derived from epithelial cells. For that 
reason, it is of crucial importance to make the correct 
diagnosis prior to therapy implementation. 
In order to specify the diagnosis, both patients 
were subjected to another FNAB. Cellular material 
was obtained from thyroid regions examined previ-
ously with cytology techniques and subjected to FACS 
examination. For this purpose, a separate needle pass 
was performed in each assessed thyroid region and 
the obtained material was washed and suspended in 
1 ml of PBS. 
Patient 1 underwent FNAB of the right lobe lesion 
(sample 1A), the left lobe lesion (sample 1B) and the 
surrounding tissue of the left lobe, without ultrasound 
features of HT (sample 1C) (Fig. 1). 
Patient 2 underwent FNAB of both lobes - left lobe 
(sample 2A), right lobe (sample 2B) and of the lesion 
close to isthmus (sample 2C) (Fig. 2). 
Flow cytometry was performed using a multicolour 
analysis technique on a FACSCanto II Cytometer (BD 
Biosciences, San Jose, CA, USA). The cells obtained with 
FNAB were incubated with a combination of phyco-
erythrin (PE), perdin chlorophyll protein (PerCP), and 
fluorescein isothiocyanate (FITC) conjugated antibodies 
specific for particular antigens: CD3+, CD5+, CD8+, 
CD10+, CD19+, CD20+, CD22+, CD38+, and κ and 
λ light chains. All antibodies were purchased from BD 
Biosciences (San Jose, CA, USA). A population of 10,000 
cells was considered sufficient for phenotypic analysis 
and the expression of each antigen was quantified as 
a percentage of the whole population with FACSDiva 
software (BD Biosciences, San Jose, CA, USA). The diag-
nostic criteria of MALT B-cell lymphoma were based on 
the evaluation of immunoglobulin light chain restriction 
in combination with an assessment of surface molecule 
expression pattern characteristic for a clonal population 
of B-lymphocytes [14, 26]. 
Light chain evaluation is regarded as a crucial step 
in the distinction between monoclonal (neoplastic) 
and polyclonal (reactive) B cell expansion. The κ/λ 
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ratio in the 0.5–3.0 range is considered as typical for 
benign processes [7]. Accordingly, many authors have 
proposed κ/λ ratio > 3–4.0 or λ/κ ratio > 2:1 as confirm-
ing monoclonality in the diagnosis of lymphoma [2, 
27, 28]. However, clonal bands have been also reported 
in patients with a classical course of HT. Due to these 
observations, some authors have suggested more strict 
criteria of B cell clonal expansion with κ/λ ratios > 6.0 
(> 10.0) or < 0.3 as definite evidence of monoclonality 
[29–32]. In cases of unclear monoclonality or suspected 
loss of light chain expression (cumulative number 
of κ and λ expressing cells does not approximate 
the number of B cells), further immunophenotyp-
ing with B- and T-cell markers has been indicated as 
a very helpful tool in precise lymphoma diagnosis and 
characterisation [33].
Results
Taking into consideration the abovementioned stud-
ies, in our analysis we adapted an algorithm pro-
posed by Zardawi et al. for the FACS based analysis 
of FNAB material in the diagnosis of lymphoma [2], 
with modifications necessary for the diagnosis of le-
sions in extranodal localisations. In order to properly 
differentiate from HT immune infiltrates, light chain 
restriction criteria were set as κ/λ ratio > 6.0 or < 0.3. 
In the absence of light chain restriction, CD20 positiv-
ity exceeding 85% of the whole cellular fraction was 
set as confirmation of B-cell lymphoma. CD5 and 
CD10 molecules served as further characteristics of 
B cell lymphoproliferative processes characteristic 
for extranodal localisation (e.g. MALT-L). Of note, co-
expression of both B and T cells antigens was regarded 
as very characteristic for HT [18].
The FACS analysis of FNAB material obtained from 
our patients did not show any definite signs of light 
chain restriction in the examined thyroid lesions (Tables 
I and II). Nonetheless, in the sample 2B, representing 
a cytologically HT picture, κ/λ ratio assessment resulted 
in a borderline value (κ/λ = 0.31, Table II). However, fur-
ther immunophenotyping confirmed clonal expansion 
of B cells in none of the examined thyroid regions (in-
cluding lesion 2B) (Tables I and II). The predominance 
of cells expressing B-cell antigens (CD19 and CD20) over 
T cells (CD3 positive cells) was only observed in sample 
1C, representing material from the thyroid region with 
normal ultrasound structure (the area surrounding the 
focal lesion in the left lobe of patient 1). Interestingly, 
sample 1C was also characterised by the lowest percent-
age of lymphocytes compared to other FNAB samples 
from patient 1 (16.55 vs. 42.5% and 43.34%) and samples 
obtained from patient 2 where lymphocytes exceeded 
70% of cellular FNAB fraction in all examined regions 
(Tables I and II).
Figure 2. Ultrasound image of thyroid gland of Patient 2. Arrow 
indicates thyroid region subjected to FNAB (sample 2C) — solid, 
heterogeneous, hypoechogenic structure of focal lesion close to 
isthmus with hyperechogenic spots (probably microcalcifications) 
and poorly defined margin, without a halo
Rycina 2. Pacjent 2 — miejsce aspiracji próbki 2C — lita, 
niejednorodna, hipoechogeniczna struktura zmiany ogniskowej 
okolicy cieśni z hiperechogenicznymi punktami (prawdopodobnie 
mikrozwapnieniami) i zatartym brzegiem bez otoczki typu „halo”
Figure 1. Ultrasound image of thyroid gland of Patient 1. Arrows 
indicate thyroid regions subjected to FNAB. Sample 1A — solid, 
heterogeneous, hypoechogenic structure of right lobe; sample 1B 
— solid, heterogeneous, hypoechogenic structure of ‘taller-than-
wide’ focal lesion in left thyroid lobe with poorly defined margin, 
without a halo; sample 1C — normoechogenic structure of tissue 
surrounding left lobe lesion
Rycina 1. Pacjent 1 — miejsca aspiracji próbek. Próbka 1A — 
lita, niejednorodna, hipoechogeniczna struktura płata prawego, 
próbka 1B — lita, niejednorodna, hipoechogeniczna struktura 
“wyższej niż szerszej” zmiany ogniskowej płata lewego o zatartym 
brzegu bez otoczki typu „halo”; próbka 1C — normoechogeniczna 
struktura tkanki otaczającej zmianę w lewym płacie
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Discussion
These findings demonstrate that the morphological 
lesions in thyroid gland observed in US may correlate 
with the intensity and quality of immune infiltration. 
The differences between patients may be associated 
with different phases of disease activity, as well as with 
the level of concomitant fibrosis (e.g. patient 1), which 
found its confirmation in histopathology examination 
(see below). Furthermore, various immunophenotypes 
of infiltrates in particular thyroid foci in the same patient 
may also suggest an existence of different types of local 
immune reactions. Such an assumption concords with 
the study by Zeppa et al. who described two main im-
munophenotypes occurring in HT: B-cell lesions with 
a significant presence of CD19 positive cells (≥ 20%) and 
T-cell lesions with a prevalence of CD3, CD5 express-
ing cells and CD19 positive cells not exceeding 20% of 
cellular fraction. According to these authors, there is 
a relationship between clinical symmetrical enlarge-
ment and T-cell phenotype as well as between nodular 
presentation and B-cell phenotype [9]. According to this 
qualification, in our study Sample 1B was characterised 
by T-cell pattern, whereas samples 1A, 2A, 2B and 2C 
represented B-cell pattern.
Unconfirmed MALT-L diagnosis and the interme-
diate ultrasound risk score of malignancy were the 
reasons for qualification of both our patients to surgery. 
Histopathological findings clearly ruled out the diag-
nosis of lymphoma of the thyroid. In Case 1, chronic 
thyroiditis with intensive fibrosis features was found. 
In Case 2, chronic thyroiditis was diagnosed. In this 
context, there were surprising differences in the clinical 
course: a very quickly enlarging tumour characterised 
euthyroid patient 1, whereas indolent behaviour char-
acterised hypothyroid patient 2.
Taken together, on the basis of the presented two 
clinical cases, we believe that FACS can be a very use-
ful and reliable complementary diagnostic measure in 
FNAB based differential diagnosis of lymphoprolifera-
tive thyroid disorders. However, further studies includ-
ing larger groups of patients are required to define exact 
clinical applications. Moreover, implementation of this 
method requires effective co-operation between clini-
cians and pathologists specialist both in haematology 
and in flow cytometry performance and interpretation.
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